Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
PubMed
21178266
DOI
10.3233/cbm-2010-0150
PII: DK294H60687747N6
Knihovny.cz E-zdroje
- MeSH
- androgenní receptory genetika metabolismus MeSH
- butyráty metabolismus farmakologie terapeutické užití MeSH
- časové faktory MeSH
- histondeacetylasa 2 metabolismus MeSH
- histondeacetylasy metabolismus MeSH
- imunoprecipitace MeSH
- inhibitory histondeacetylas terapeutické užití MeSH
- korepresor 2 jaderného receptoru genetika metabolismus MeSH
- kyseliny hydroxamové metabolismus farmakologie terapeutické užití MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádory prostaty farmakoterapie genetika metabolismus MeSH
- regulace genové exprese u nádorů MeSH
- vazba proteinů genetika MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Názvy látek
- androgenní receptory MeSH
- AR protein, human MeSH Prohlížeč
- butyráty MeSH
- histondeacetylasa 2 MeSH
- histondeacetylasy MeSH
- histone deacetylase 3 MeSH Prohlížeč
- inhibitory histondeacetylas MeSH
- korepresor 2 jaderného receptoru MeSH
- kyseliny hydroxamové MeSH
- trichostatin A MeSH Prohlížeč
Signaling through the androgen receptor (AR) plays a critical role in prostate cancer progression. The AR is a classical nuclear receptor (NR) providing a link between signaling molecule and transcription response. Histone deacetylase inhibitors (HDACI) have antiproliferative and proapoptotic effects on prostate cancer cells and their implication in silence AR signaling may have potential therapeutic use. We aimed to study the inhibitory effects of the corepressor SMRT (Silencing Mediator for Retinoid and Thyroid hormone receptors) which forms a complex together with nuclear receptor corepressor (N-CoR) and with histone deacetylase 3 (HDAC3) on AR activity. The androgen-sensitive prostate cancer cell line LNCaP and androgen-insensitive prostate cancer cell line C4-2 both AR-positive, and androgen-insensitive DU145 and PC3 prostate cancer cell lines were treated with two HDACIs, sodium butyrate (NaB) and/or trichostatin A (TSA). We amplified immunoprecipitated DNA by conventional PCR and in the following step we used the chromatin immunoprecipitation (ChIP) analysis coupled with quantitative PCR for monitoring NaB induced formation of AR-SMRT/N-CoR complex binding on the PSA promoter. The co-immunoprecipitation assay revealed increase in AR-SMRT formation in NaB treated cells. Simultaneously, the Western blot analysis showed a significant decrease in AR protein expression. Furthermore, we estimated the reduced presence of HDAC2 and HDAC3 proteins by NaB and TSA treatment in AR-negative DU145 cell line. In conclusion, the inhibitory effect of NaB on AR gene expression seems to be specific and unique for prostate cancer AR-positive cell lines and corresponds with its ability to stimulate AR-SMRT complex formation. We suggest that AR and SMRT/N-CoR corepressors may form a stable complex in vitro and NaB may facilitate the interaction between AR nuclear steroid receptor and SMRT corepressor protein.
Citace poskytuje Crossref.org